Pentiapine, with the CAS number 81382-51-6, is an atypical antipsychotic agent that belongs to the class of compounds known as dibenzodiazepines. It is primarily characterized by its ability to modulate neurotransmitter activity in the brain, particularly affecting serotonin and dopamine receptors, which plays a crucial role in its therapeutic effects. Pentiapine is known for its potential use in the treatment of various psychiatric disorders, including schizophrenia and bipolar disorder. The compound exhibits a unique pharmacological profile, which may contribute to a lower incidence of certain side effects commonly associated with traditional antipsychotics. In terms of physical properties, pentiapine is typically presented as a white to off-white crystalline powder, and it is soluble in organic solvents while having limited solubility in water. As with many pharmaceuticals, its safety and efficacy are evaluated through clinical trials, and it is essential to consider potential side effects and contraindications when prescribing or using this medication.

Pentiapine

81382-51-6: Pentiapine, with the CAS number 81382-51-6, is an atypical antipsychotic agent that belongs to the class of compounds known as dibenzodiazepines. It is primarily characterized by its ability to modulate neurotransmitter activity in the brain, particularly affecting serotonin and dopamine receptors, which plays a crucial role in its therapeutic effects. Pentiapine is known for its potential use in the treatment of various psychiatric disorders, including schizophrenia and bipolar disorder. The compound exhibits a unique pharmacological profile, which may contribute to a lower incidence of certain side effects commonly associated with traditional antipsychotics. In terms of physical properties, pentiapine is typically presented as a white to off-white crystalline powder, and it is soluble in organic solvents while having limited solubility in water. As with many pharmaceuticals, its safety and efficacy are evaluated through clinical trials, and it is essential to consider potential side effects and contraindications when prescribing or using this medication.

Pentiapine (CGS 10746) is a novel inhibitor of dopamine release.

CAS 81382-51-6

Pentiapine

Pentiapine

Ref: 54-BUP08540

Pentiapine

Ref: TM-T12405